Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

BRISBANE, Calif.: BRISBANE, Calif., Jan. 19, 2022 /PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from public and proprietary microbiome data, today announced the appointment of Joseph Dal Porto, Ph.D., as Chief Scientific Officer. He brings more than...

Click to view original post